Skip to main content
Download PDF

Correction: Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer

Journal of Nanobiotechnology volume 21, Article number: 498 (2023) Cite this article

The Original Article was published on 24 October 2023

Correction: Chen et al. Journal of Nanobiotechnology (2023) 21:385

https://doi.org/10.1186/s12951-023-02154-0

In this article the statement in the Funding information section was incorrectly given as ‘This research was financially backed by the National Science and Technology Council (NSTC110-2628-B-110-004, NSTC111-2628-B-006-023, NSTC112-2628-B-006-015) and National Health Research Institutes (NHRI-EX112-11226EI), Taiwan’ and should have read

‘This work was financially supported by the National Science and Technology Council (NSTC111- 2628-B-006-023 and NSTC112-2628-B-006-015), National Health Research Institutes (NHRI-EX112- 11226EI), and Kaohsiung Armed Forces General Hospital (KAFGH_D_110025), Taiwan’.

The original article [1] has been corrected.

References

  1. Chen YT, Luo YX, Chan SH, et al. Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer. J Nanobiotechnol. 2023;21(1):385.

Download references

Author information

Author notes

  1. Wen-Yi Chiu and Hung-Wei Yang jointly supervised this work.

Authors and Affiliations

  1. Department of Biomedical Engineering, National Cheng Kung University, Tainan, 70101, Taiwan

    Ying-Tzu Chen & Hung-Wei Yang

  2. Department of Neurosurgery, Neuroscience Research Center, Chang Gung Memorial Hospital, Linkou, 33305, Taoyuan, Taiwan

    Ying-Tzu Chen

  3. Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan

    Ying-Xiang Luo & Wen-Yi Chiu

  4. School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan

    Shih-Hsuan Chan

  5. Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung, 40402, Taiwan

    Shih-Hsuan Chan

  6. Chinese Medicine Research Center, China Medical University, Taichung, 40402, Taiwan

    Shih-Hsuan Chan

  7. Department of Family Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, 80284, Taiwan

    Wen-Yi Chiu

  8. Medical Device Innovation Center, National Cheng Kung University, Tainan, 70101, Taiwan

    Hung-Wei Yang

Authors
  1. Ying-Tzu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying-Xiang Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shih-Hsuan Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wen-Yi Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hung-Wei Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wen-Yi Chiu or Hung-Wei Yang.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12951-023-02154-0.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, YT., Luo, YX., Chan, SH. et al. Correction: Dual antibody-aided mesoporous nanoreactor for H2O2 self-supplying chemodynamic therapy and checkpoint blockade immunotherapy in triple-negative breast cancer. J Nanobiotechnol 21, 498 (2023). https://doi.org/10.1186/s12951-023-02233-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12951-023-02233-2

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us